We are live on ! Find out more
PAVMZ

PAVmed Inc. Series Z Warrant

Delisted

PAVMZ was delisted on the 30th of April, 2025.

6 hedge funds and large institutions have $1.63M invested in PAVmed Inc. Series Z Warrant in 2019 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

15% more capital invested

Capital invested by funds: $1.42M → $1.63M (+$208K)

14% less funds holding

Funds holding: 76 (-1)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
6
Holders Change
-1
Holders Change %
-14.29%
% of All Funds
0.13%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
Increased
1
Reduced
2
Closed
1
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
LCS
Levin Capital Strategies
New York
+$6.43K

PAVMZ Hedge Fund Activity: Q1 2019 in Review

6 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in PAVmed Inc. Series Z Warrant (PAVMZ) for Q1 2019, worth a combined $1.63M — up 15% from $1.42M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of PAVMZ and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.

The largest buyer was Levin Capital Strategies, adding an estimated $6.43K. The largest seller was Sabby Management, cutting an estimated $90K.

  • 6 institutional investors held PAVmed Inc. Series Z Warrant (PAVMZ) as of Q1 2019, down from 7 in Q4 2018.
  • Funds reported $1.63M of PAVmed Inc. Series Z Warrant stock for Q1 2019, up 15% quarter-over-quarter.
  • 0 funds opened new PAVmed Inc. Series Z Warrant positions in Q1 2019 and 1 closed out, a net change of -1 holder.
  • The largest PAVmed Inc. Series Z Warrant buyer in Q1 2019 was Levin Capital Strategies, an estimated $6.43K added.
  • The largest PAVmed Inc. Series Z Warrant seller in Q1 2019 was Sabby Management, an estimated $90K sold.

Based on aggregated 13F filings for Q1 2019.